These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6630371)

  • 1. On-line diode array UV-visible spectrometry in screening for drugs and drug metabolites by high-performance liquid chromatography.
    Overzet F; Rurak A; van der Voet H; Drenth BF; Ghijsen RT; de Zeeuw RA
    J Chromatogr; 1983 Sep; 267(2):329-45. PubMed ID: 6630371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multichannel diode array UV-visible spectrophotometer as detector in screening for unknown butoprozine metabolites in dog bile by high-performance liquid chromatography.
    Overzet F; Ghijsen RT; Drenth BF; De Zeeuw RA
    J Chromatogr; 1982 May; 240(1):190-5. PubMed ID: 7096514
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatography in the elucidation of the metabolic fate of butoprozine: screening for unknown metabolites in the rat.
    Drenth BF; de Zeeuw RA
    J Chromatogr; 1980 Apr; 191():109-14. PubMed ID: 7380960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line screening for drug metabolites by high-performance liquid chromatography with a diode array UV detector.
    Zech K; Huber R; Elgass H
    J Chromatogr; 1983 Dec; 282():161-7. PubMed ID: 6674313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and inter-species comparisons of biliary metabolic profiles of butoprozine by high performance liquid chromatography.
    Overzet F; de Zeeuw RA
    Xenobiotica; 1985 Jan; 15(1):1-10. PubMed ID: 3984379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for impurities in butoprozine.
    Drenth BF; Jagersma T; Wormeester AJ; de Zeeuw RA
    Pharm Weekbl Sci; 1983 Aug; 5(4):149-52. PubMed ID: 6622208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.
    Görög S; Bihari M; Csizér E; Dravetz F; Gazdag M; Herényi B
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):85-92. PubMed ID: 8833970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural identification of drug metabolites using thermospray liquid chromatography/mass spectrometry.
    Beattie IG; Blake TJ
    Biomed Environ Mass Spectrom; 1989 Oct; 18(10):872-7. PubMed ID: 2804435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Myung SW; Chang YJ; Min HK; Kim DH; Kim M; Kang TK; Yoo EA; Sohn YT; Yim YH
    Rapid Commun Mass Spectrom; 2000; 14(21):2046-54. PubMed ID: 11085417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-performance liquid chromatography-diode array detection in forensic toxicology.
    Koves EM
    J Chromatogr A; 1995 Feb; 692(1-2):103-19. PubMed ID: 7719450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of drugs in human serum by high-performance liquid chromatography with photodiode array detection and a search algorithm for ultraviolet spectra.
    Minder EI; Schaubhut R; Minder CE; Vonderschmitt DJ
    J Chromatogr; 1987 Aug; 419():135-54. PubMed ID: 3667773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD).
    Pragst F; Herzler M; Erxleben BT
    Clin Chem Lab Med; 2004; 42(11):1325-40. PubMed ID: 15576293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic studies of explosives. II. High-performance liquid chromatography-mass spectrometry of metabolites of 2,4,6-trinitrotoluene.
    Yinon J; Hwang DG
    J Chromatogr; 1985 Apr; 339(1):127-37. PubMed ID: 4019662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of chiral drugs by liquid chromatography based upon diastereomer formation with chiral derivatization reagents.
    Toyo'oka T
    J Biochem Biophys Methods; 2002 Dec; 54(1-3):25-56. PubMed ID: 12543490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing role of ultraviolet spectroscopy in drug analysis.
    Görög S; Rényei M; Herényi B
    J Pharm Biomed Anal; 1989; 7(12):1527-33. PubMed ID: 2490539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indirect spectrophotometric detection by reversed-phase liquid chromatography. Application in drug analysis].
    Herne P
    J Pharm Belg; 1990; 45(2):151-9. PubMed ID: 2192023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical tools and approaches for metabolite identification in early drug discovery.
    Chen Y; Monshouwer M; Fitch WL
    Pharm Res; 2007 Feb; 24(2):248-57. PubMed ID: 17048114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and evaluation of a diluter-ultraviolet spectrophotometric analysis system for the determination of drugs in solutions and suspensions.
    Law B; Hough P
    J Pharm Biomed Anal; 1997 Feb; 15(5):587-92. PubMed ID: 9127270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination of ampicillin and its metabolites in rat plasma, bile and urine by post-column degradation with sodium hypochlorite.
    Haginaka J; Wakai J; Yasuda H; Uno T; Takahashi K; Katagi T
    J Chromatogr; 1987 Jul; 400():101-11. PubMed ID: 3667740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.